This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Oncotelic Therapeutics (OTLC) maintained its $388M GMP Biotechnology JV valuation in Q1 2026, backed by independent ASC 820 assessment. Its partnership model advances a multi-billion-dollar oncology pipeline while limiting cash burn. #Biotech #Oncology
2026-06-02T14:14:24.773Z